Angelman syndrome due to a termination codon mutation of the UBE3A gene

Almundher Al-Maawali, Jerry MacHado, Ping Fang, Lucie Dupuis, Hannaneh Faghfoury, Roberto Mendoza-Londono

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Angelman syndrome is a neurodevelopmental disorder characterized by global developmental delay, mental retardation, seizures, microcephaly, and severe speech delay. It may be caused by deletion of chromosome region 15q11.2 of the maternally inherited chromosome, mutations in the UBE3A gene, uniparental disomy, or imprinting defects. Most patients with this diagnosis have a severe phenotype, and a few have a mild form of the disease. We report a patient with a novel mutation in the UBE3A gene that consists of a deletion of the termination codon (c.2556-*+6del GTAAAACAAA) and results in an elongated protein E3 ubiquitin-protein ligase. Our patient has a mild phenotype compared with other patients in general and specifically to patients with UBE3A mutations. He has mild developmental delay, moderate speech delay, and no seizures. Recognition of this genotype-phenotype correlation will allow better genetic counseling to other patients with similar stop codon mutations.

Original languageEnglish
Pages (from-to)392-395
Number of pages4
JournalJournal of Child Neurology
Volume28
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Angelman Syndrome
Terminator Codon
Mutation
Genes
Language Development Disorders
Seizures
Uniparental Disomy
Phenotype
Microcephaly
Chromosome Deletion
Ubiquitin-Protein Ligases
Genetic Counseling
Genetic Association Studies
Intellectual Disability
Chromosomes

Keywords

  • Angelman syndrome
  • deletion
  • mutation
  • phenotype
  • UBE3A

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Al-Maawali, A., MacHado, J., Fang, P., Dupuis, L., Faghfoury, H., & Mendoza-Londono, R. (2013). Angelman syndrome due to a termination codon mutation of the UBE3A gene. Journal of Child Neurology, 28(3), 392-395. https://doi.org/10.1177/0883073812443591

Angelman syndrome due to a termination codon mutation of the UBE3A gene. / Al-Maawali, Almundher; MacHado, Jerry; Fang, Ping; Dupuis, Lucie; Faghfoury, Hannaneh; Mendoza-Londono, Roberto.

In: Journal of Child Neurology, Vol. 28, No. 3, 03.2013, p. 392-395.

Research output: Contribution to journalArticle

Al-Maawali, A, MacHado, J, Fang, P, Dupuis, L, Faghfoury, H & Mendoza-Londono, R 2013, 'Angelman syndrome due to a termination codon mutation of the UBE3A gene', Journal of Child Neurology, vol. 28, no. 3, pp. 392-395. https://doi.org/10.1177/0883073812443591
Al-Maawali, Almundher ; MacHado, Jerry ; Fang, Ping ; Dupuis, Lucie ; Faghfoury, Hannaneh ; Mendoza-Londono, Roberto. / Angelman syndrome due to a termination codon mutation of the UBE3A gene. In: Journal of Child Neurology. 2013 ; Vol. 28, No. 3. pp. 392-395.
@article{3fd9ea913a774830bd5d52d7408c247d,
title = "Angelman syndrome due to a termination codon mutation of the UBE3A gene",
abstract = "Angelman syndrome is a neurodevelopmental disorder characterized by global developmental delay, mental retardation, seizures, microcephaly, and severe speech delay. It may be caused by deletion of chromosome region 15q11.2 of the maternally inherited chromosome, mutations in the UBE3A gene, uniparental disomy, or imprinting defects. Most patients with this diagnosis have a severe phenotype, and a few have a mild form of the disease. We report a patient with a novel mutation in the UBE3A gene that consists of a deletion of the termination codon (c.2556-*+6del GTAAAACAAA) and results in an elongated protein E3 ubiquitin-protein ligase. Our patient has a mild phenotype compared with other patients in general and specifically to patients with UBE3A mutations. He has mild developmental delay, moderate speech delay, and no seizures. Recognition of this genotype-phenotype correlation will allow better genetic counseling to other patients with similar stop codon mutations.",
keywords = "Angelman syndrome, deletion, mutation, phenotype, UBE3A",
author = "Almundher Al-Maawali and Jerry MacHado and Ping Fang and Lucie Dupuis and Hannaneh Faghfoury and Roberto Mendoza-Londono",
year = "2013",
month = "3",
doi = "10.1177/0883073812443591",
language = "English",
volume = "28",
pages = "392--395",
journal = "Journal of Child Neurology",
issn = "0883-0738",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Angelman syndrome due to a termination codon mutation of the UBE3A gene

AU - Al-Maawali, Almundher

AU - MacHado, Jerry

AU - Fang, Ping

AU - Dupuis, Lucie

AU - Faghfoury, Hannaneh

AU - Mendoza-Londono, Roberto

PY - 2013/3

Y1 - 2013/3

N2 - Angelman syndrome is a neurodevelopmental disorder characterized by global developmental delay, mental retardation, seizures, microcephaly, and severe speech delay. It may be caused by deletion of chromosome region 15q11.2 of the maternally inherited chromosome, mutations in the UBE3A gene, uniparental disomy, or imprinting defects. Most patients with this diagnosis have a severe phenotype, and a few have a mild form of the disease. We report a patient with a novel mutation in the UBE3A gene that consists of a deletion of the termination codon (c.2556-*+6del GTAAAACAAA) and results in an elongated protein E3 ubiquitin-protein ligase. Our patient has a mild phenotype compared with other patients in general and specifically to patients with UBE3A mutations. He has mild developmental delay, moderate speech delay, and no seizures. Recognition of this genotype-phenotype correlation will allow better genetic counseling to other patients with similar stop codon mutations.

AB - Angelman syndrome is a neurodevelopmental disorder characterized by global developmental delay, mental retardation, seizures, microcephaly, and severe speech delay. It may be caused by deletion of chromosome region 15q11.2 of the maternally inherited chromosome, mutations in the UBE3A gene, uniparental disomy, or imprinting defects. Most patients with this diagnosis have a severe phenotype, and a few have a mild form of the disease. We report a patient with a novel mutation in the UBE3A gene that consists of a deletion of the termination codon (c.2556-*+6del GTAAAACAAA) and results in an elongated protein E3 ubiquitin-protein ligase. Our patient has a mild phenotype compared with other patients in general and specifically to patients with UBE3A mutations. He has mild developmental delay, moderate speech delay, and no seizures. Recognition of this genotype-phenotype correlation will allow better genetic counseling to other patients with similar stop codon mutations.

KW - Angelman syndrome

KW - deletion

KW - mutation

KW - phenotype

KW - UBE3A

UR - http://www.scopus.com/inward/record.url?scp=84873656597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873656597&partnerID=8YFLogxK

U2 - 10.1177/0883073812443591

DO - 10.1177/0883073812443591

M3 - Article

C2 - 22566713

AN - SCOPUS:84873656597

VL - 28

SP - 392

EP - 395

JO - Journal of Child Neurology

JF - Journal of Child Neurology

SN - 0883-0738

IS - 3

ER -